These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11000170

  • 1. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography?
    Brown RR, Clarke DW, Daffner RH.
    AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170
    [Abstract] [Full Text] [Related]

  • 2. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L, Funke M, Fischer U, Keating D, Oestmann J, Grabbe E.
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
    van Bree H, Van Ryssen B, Degryse H, Ramon F.
    Am J Vet Res; 1995 Mar; 56(3):286-8. PubMed ID: 7771693
    [Abstract] [Full Text] [Related]

  • 4. MR arthrography: impact of steroids, local anesthetics, and iodinated contrast material on gadolinium signal intensity in phantoms at 1.5 and 3.0 T.
    Ugas MA, Huynh BH, Fox MG, Patrie JT, Gaskin CM.
    Radiology; 2014 Aug; 272(2):475-83. PubMed ID: 24661248
    [Abstract] [Full Text] [Related]

  • 5. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G, Rinck PA, Børseth A.
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [Abstract] [Full Text] [Related]

  • 6. Incidence of immediate gadolinium contrast media reactions.
    Prince MR, Zhang H, Zou Z, Staron RB, Brill PW.
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [Abstract] [Full Text] [Related]

  • 7. [Technical considerations for injection of a mixture of iodinated contrast material and Artirem for combined CT and MR arthrography].
    Detreille R, Sauer B, Zabel JP, Batch T, Zhu X, Blum A.
    J Radiol; 2007 Jun; 88(6):863-9. PubMed ID: 17652979
    [Abstract] [Full Text] [Related]

  • 8. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ, Mack MG, Juergens M, Stark M, Pegios W, Bergman C, Grevers G, Western A.
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP, Szopinski KT, Cohan RH, Mermillod B, Ellis JH.
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [Abstract] [Full Text] [Related]

  • 10. Effects of iodinated contrast and field strength on gadolinium enhancement: implications for direct MR arthrography.
    Montgomery DD, Morrison WB, Schweitzer ME, Weishaupt D, Dougherty L.
    J Magn Reson Imaging; 2002 Mar; 15(3):334-43. PubMed ID: 11891980
    [Abstract] [Full Text] [Related]

  • 11. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A, Aznar L, Alamar R, Castelló JV.
    Med Clin (Barc); 1996 Feb 10; 106(5):197. PubMed ID: 8684023
    [No Abstract] [Full Text] [Related]

  • 12. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW, Chang KH, Choi DS, Han MH, Han MC.
    AJR Am J Roentgenol; 1995 Nov 10; 165(5):1251-5. PubMed ID: 7572513
    [Abstract] [Full Text] [Related]

  • 13. Potential contrast agents for MR arthrography: in vitro evaluation and practical observations.
    Hajek PC, Sartoris DJ, Neumann CH, Resnick D.
    AJR Am J Roentgenol; 1987 Jul 10; 149(1):97-104. PubMed ID: 3495998
    [Abstract] [Full Text] [Related]

  • 14. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC, Brant-Zawadzki M.
    AJR Am J Roentgenol; 1993 Jan 10; 160(1):153-7. PubMed ID: 8416615
    [Abstract] [Full Text] [Related]

  • 15. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
    van Gils AP, van den Berg R, Falke TH, Bloem JL, Prins HJ, Dillon EH, van der Mey AG, Pauwels EK.
    AJR Am J Roentgenol; 1994 Jan 10; 162(1):147-53. PubMed ID: 8273654
    [Abstract] [Full Text] [Related]

  • 16. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
    Beltran J, Chandnani V, McGhee RA, Kursunoglu-Brahme S.
    AJR Am J Roentgenol; 1991 Mar 10; 156(3):457-66. PubMed ID: 1899738
    [Abstract] [Full Text] [Related]

  • 17. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM, Mintz RD.
    AJR Am J Roentgenol; 1995 Mar 10; 164(3):743-4. PubMed ID: 7863905
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV, Balzer T, Esser M, Kashanian FK, Paul P, Niendorf HP.
    Invest Radiol; 2006 Jun 10; 41(6):491-9. PubMed ID: 16763467
    [Abstract] [Full Text] [Related]

  • 19. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections.
    Abujudeh HH, Kosaraju VK, Kaewlai R.
    AJR Am J Roentgenol; 2010 Feb 10; 194(2):430-4. PubMed ID: 20093606
    [Abstract] [Full Text] [Related]

  • 20. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N, Ramón E, Gonzalez del Valle L, Ruano M, Jiménez E.
    Ann Pharmacother; 1997 Mar 10; 31(3):374. PubMed ID: 9066954
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.